Related Experiment Videos
Somatostatin modulates dopamine release in rat retina
Evangelia Kouvidi1, Zeta Papadopoulou-Daifoti, Kyriaki Thermos
1University of Crete, Faculty of Medicine, Department of Basic Sciences, Laboratory of Pharmacology, Heraklion, Crete 71110, Greece.
Neuroscience Letters
|September 27, 2005
Summary
Somatostatin modulates dopamine release in rat retinas, primarily through somatostatin receptor 1 (sst1) and somatostatin receptor 2 (sst2) activation. This study reveals a novel neuromodulatory role for somatostatin in retinal dopamine regulation.
Area of Science:
- Neuroscience
- Ophthalmology
- Endocrinology
Background:
- Dopamine plays a crucial role in retinal function.
- The neuromodulatory effects of somatostatin in the retina are not fully understood.
Purpose of the Study:
- To investigate the role of somatostatin in modulating dopamine release in rat retinas.
- To identify the specific somatostatin receptor subtypes involved in this process.
Main Methods:
- Ex vivo study using rat retinal explants.
- Quantification of dopamine levels using high-performance liquid chromatography (HPLC) with electrochemical detection.
- Application of somatostatin and selective somatostatin receptor ligands.
Main Results:
- Somatostatin increased dopamine levels in a concentration-dependent manner.
- The sst(2) antagonist CYN154806 reversed the effect of somatostatin.
- sst(1) and sst(2) receptor agonists increased dopamine release, while sst(3) activation had no effect.
Conclusions:
- Somatostatin significantly influences dopamine release in the rat retina.
- sst(1) and sst(2) somatostatin receptors mediate these effects, highlighting their neuromodulatory role in retinal dopamine regulation.